We found that rats exhibited dyslipidemia and glucose intolerance during UA stimulation and that the inhibition of hypothalamic inflammation by an NF-κB inhibitor remarkably ameliorated glucose intolerance. The gene discussed is NFKB1; the disease is metabolic syndrome.